University of California Davis Comprehensive Cancer Center is a clinical research site located in Sacramento, California, United States 95817.
Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.
University of California Davis Comprehensive Cancer Center has participated in 539 clinical trials with 309 currently active.
Therapeutic areas: B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like.
Sponsors: Children's Oncology Group, National Cancer Institute (NCI), Mamta Parikh.
Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of California Davis Comprehensive Cancer Center has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of California Davis Comprehensive Cancer Center has 539 clinical trials on record, with 309 currently active. Their work covers B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like.
University of California Davis Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.